A US company has tested a brain implant in four Chinese patients in Shanghai, a rare sign of cooperation as the two countries compete to develop the most advanced neurotechnology.
Ike Swetlitz is a Health Reporter at a leading publication. He focuses on critical areas such as healthcare administration, patient care, and the intersection of cybercrime with the healthcare system, as well as trends in retail and consumer behavior analytics. Ike's work has been featured in prominent outlets including Financial Post, Bloomberg Law, TIME, and The Boston Globe.
